An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells

Breast cancer remains one of the leading causes of cancer-associated death worldwide. Conventional treatment is associated with substantial toxicity and suboptimal efficacy. We, therefore, developed and evaluated the in vitro efficacy of an autologous dendritic cell (DC) vaccine to treat breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomasicchio, Michele, Semple, Lynn, Esmail, Aliasgar, Meldau, Richard, Randall, Philippa, Pooran, Anil, Davids, Malika, Cairncross, Lydia, Anderson, David, Downs, Jennifer, Malherbe, Francois, Novitzky, Nicolas, Panieri, Eugenio, Oelofse, Suzette, Londt, Rolanda, Naiker, Thurandrie, Dheda, Keertan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326986/
https://www.ncbi.nlm.nih.gov/pubmed/30283982
http://dx.doi.org/10.1007/s00262-018-2238-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326986/
https://www.ncbi.nlm.nih.gov/pubmed/30283982
http://dx.doi.org/10.1007/s00262-018-2238-5

Ejemplares similares